Changes in functional status associated with radiation for prostate cancer in older veterans. Issue 5 (June 2021)

• Record Type: Journal Article
• Authors: Ursem, Carling; Diaz-Ramirez, L. Grisell; Boscardin, John; Lee, Sei
• Is Part Of: Journal of geriatric oncology. Volume 12:Issue 5(2021)
• Page Start: 808
• Page End: 812
• Publication Date: 2021-06
• Subjects: Prostate cancer -- Prostate radiation -- Functional status -- Geriatric oncology; Geriatric oncology -- Periodicals; Neoplasms -- Periodicals; Aged -- Periodicals; Geriatric oncology; Electronic journals; Periodicals; 618.976994005
• DOI: 10.1016/j.jgo.2020.12.011
• Languages: English
• ISSNs: 1879-4068

Abstract

Abstract: Background: Although older men value maintaining independence and avoiding functional decline, little is known about their functional trajectories with receipt of prostate radiation. Methods: We performed a retrospective cohort study including veterans age 65+ with localized prostate cancer who resided in a VA nursing facility while receiving prostate radiation from 2005 to 2015. We evaluated the change in Minimum Data Set (MDS) activities of daily living (ADL) score during 6 months from the start of treatment. Because prior studies have shown Charlson Comorbidity Index (CCI) to be a strong predictor of treatment-related toxicity, analysis included interaction with CCI. Results: We identified 487 patients with median age 73 (range 65–94). For the average patient in our cohort, the predicted MDS-ADL score worsened from 2.9 (95% CI 2.4–3.6) at the start of radiation to 3.8 (95% CI 3.1–4.8) at 3 months and then 4.5 (95% CI 3.5–5.7) at month 6. Patients with greater comorbidity (CCI ≥ 4) had worse functional outcomes in months 0–3 compared to patients with less comorbidity (CCI 0–3). MDS-ADL score worsened by 1.9 in the CCI ≥4 patients compared to 0.3 in the CCI 0–3 group During months 3–6, patients in both Charlson groups experienced similar worsening of MDS-ADL score. Conclusions: In a vulnerable population of older patients with localized prostate cancer, radiation was associated with a decline in functional independence. Patients with higher comorbidity experienced more severe functional decline within the first 3 months of radiation therapy. In all comorbidity levels, functional status had not returned to baseline by 6 months.